Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study

被引：0
|
作者：
Pozzilli, C. [1 ]
Phillips, J. T. [2 ]
Fox, R. J. [3 ]
Selmaj, K. [4 ]
Zhang, R. [5 ]
Novas, M. [5 ]
Sweetser, M. T. [5 ]
Gold, R. [6 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Med Univ Lodz, Lodz, Poland
[5] Biogen Idec Inc, Cambridge, MA USA
[6] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P066
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [21] PREGNANCY OUTCOMES WITH DELAYED-RELEASE DIMETHYL FUMARATE: INTERIM RESULTS FROM AN INTERNATIONAL REGISTRY
    Everage, Nicholas J.
    Liu, Shifang
    Yun, Jang
    Prada, Claudia
    Hanna, Jerome
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E22 - E22
  • [22] Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Fox, Robert J.
    Kappos, Ludwig
    Chen, Chongshu
    Parks, Becky
    Miller, Catherine
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [23] Pregnancy outcomes with delayed-release dimethyl fumarate: interim results from an international registry
    Everage, N. J.
    Liu, S.
    Yun, J.
    Prada, C.
    Hanna, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 914 - 915
  • [24] Safety and Tolerability of Oral BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis (RRMS): Interim Results from ENDORSE Extension Study
    Phillips, J. Theodore
    Fox, Robert
    Selmaj, Krzysztof
    Raghupathi, Kartik
    Yuan, Huixing
    Novas, Mark
    Sweetser, Marianne
    Viglietta, Vissia
    Dawson, Katherine
    Gold, Ralf
    NEUROLOGY, 2013, 80
  • [25] Rate of brain volume loss under long-term delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis patients: results from the ENDORSE study
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Arnold, D. L.
    Potts, J.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 48 - 48
  • [26] Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE
    Yousry, T.
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    MacManus, D.
    Sheikh, S.
    Zhang, R.
    Yang, M.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 156 - 156
  • [27] Sustained low rate of brain volume loss with long-term delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis patients: results from the ENDORSE study
    Miller, D.
    Yousry, T.
    Fox, R. J.
    Gold, R.
    Arnold, D. L.
    Potts, J.
    Marantz, J. L.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 550 - 551
  • [28] Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE
    Kurukulasuriya, N. C.
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 93 - 93
  • [29] Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up
    McCabe, PH
    Michel, NC
    Mcnew, CD
    Lehman, EB
    EPILEPSY & BEHAVIOR, 2006, 8 (03) : 601 - 605
  • [30] Six-year follow-up of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM and ENDORSE
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D.
    Zhang, R.
    Yang, M.
    Rana, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 264 - 265
12345